FBIO Fortress Biotech, Inc.
$1.93▲ +3.21%
Healthcare
Other
Volume 157.1K
Avg Volume (10D) 254.9K
Key Metrics & Fundamentals
Market Cap
$64.37M
P/E Ratio
0.7
Div Yield
0.00%
52W Range
1.83 - 4.53
% vs 50 MA
-18.25%
% vs 200 MA
-31.45%
RSI-14
37.3
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.15
Free Cash Flow
-$59.36M
Gross Rev
$18.72M
Gross Profit
$12.58M
EBITDA
$3.16M
COGS
$6.14M
Operating Exp
$22.58M
Operating Income
-$10.01M
EBIT
-$10.01M
Pretax Income
$922,000
Net Income
-$468,000
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News
Journey Medical Corporation to Participate in September 2026 Investor Conferences
GlobeNewswire · Sep 8, 2026 4:05 PM ET
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 8, 2026 8:00 AM ET
Fortress Biotech, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 8:30 AM ET
Fortress Biotech (FBIO) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 10:28 PM ET
Fortress Biotech: Q2 Earnings Snapshot
Associated Press · Aug 13, 2026 5:05 PM ET
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire · Aug 13, 2026 4:05 PM ET
Fortress Biotech Q2 Earnings Call Highlights
MarketBeat · Aug 12, 2026 7:04 PM ET
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire · Aug 12, 2026 4:01 PM ET
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
GlobeNewswire · Aug 5, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See FBIO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.